Login to Your Account


DUBLIN – The EMA aims, as best it can, to maintain a business-as-usual stance in the run-up to Brexit and the agency's associated departure from London.

LONDON – A coordinated approach to dementia drug discovery, uniting academics, industry and public and private funders, is showing signs of success in focusing research, speeding translation and de-risking the field for pharma.

LONDON – The U.K. is to move ahead with the creation of an advanced research program that will put in place large-scale infrastructures and carry out high-risk science needed to support development of entirely new industries in health care.

More EUROPE Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: